OrthogenRx, Inc. is a medical device company focused on the development and commercialization of treatments for knee pain caused by osteoarthritis (OA). OA is the most common cause of knee pain, causing sufferers significant pain and disability. OrthogenRx's knee joint pain injection products are safe, non-surgical alternatives developed to lubricate the joint and relieve mild to moderate knee pain for patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. It is our quest to help improve patient lives by getting them back to a life without OA knee pain.
At OrthogenRx, our novel strategy for achieving rapid regulatory approval and commercialization is one of the keys to our success. This is illustrated by our current portfolio of products including GenVisc 850 (sodium hyaluronate) and TriVisc (sodium hyaluronate) which provide healthcare professionals treatment options to decide what’s best for each individual patient.
By recognizing that healthcare professionals are the ones who truly make
hyaluronic acids work, OrthogenRx is committed to providing proven, safe and effective products to help make a difference – for patients and for healthcare professionals.